ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy? [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
In the biotech scene, numerous firms can harness a technological edge to improve various aspects of health and medicine. From genetic medicine to less-invasive disease diagnostics, this piece will check out three Strong-Buy-rated stocks—ZTS, EXAS, and AZN—that I view as among the most investable in the often-choppy biopharmaceutical scene. Though individual biotech and biopharmaceutical stocks may have a reputation of hitting or missing (either a drug in the pipeline passes late-stage clinical trials or it doesn't), I think the following well-run companies have distinct advantages in their corner of the biopharma scene that can help smooth out the bumps that are to be expected in investing in biotechnology innovators. Therefore, let's check in with TipRanks' Comparison Tool below to weigh in on three amazing (but not too expensive) biotech plays that currently have the hearts of many Wall Street analysts. Zoetis (NASDAQ:ZTS) With many innovative biotechnology companies investi
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- Here's Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS) [Yahoo! Finance]Yahoo! Finance
- Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- Why Exact Sciences (EXAS) Dipped More Than Broader Market Today [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook [Yahoo! Finance]Yahoo! Finance
EXAS
Earnings
- 2/21/24 - Beat
EXAS
Sec Filings
- 4/25/24 - Form 8-K
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- EXAS's page on the SEC website